Grant Details
Grant Number: |
5R01CA244673-05 Interpret this number |
Primary Investigator: |
Ferguson, Robert |
Organization: |
University Of Pittsburgh At Pittsburgh |
Project Title: |
Mobile Device Cbt for Chemotherapy-Related Cognitive Dysfunction: a Multi-Center Randomized Controlled Trial |
Fiscal Year: |
2024 |
Abstract
ABSTRACT
The proposed research will examine the efficacy of a videoconference-delivered cognitive-behavioral therapy
(CBT), Memory and Attention Adaptation Training (MAAT), in a large, multi-site, randomized controlled trial
(RCT) for breast cancer survivors with chemotherapy-related cognitive dysfunction (CRCD). Outcome
measures include assessment of both subjective and objective cognitive functioning. Another goal of the
research is to use functional MRI (fMRI) to evaluate underlying changes in brain activation patterns that are
believed to be associated with positive effects of MAAT. Recent analyses by the MPIs have demonstrated
enhanced working memory-related cortical activation following MAAT treatment among individuals with
traumatic brain injury (TBI). The present work seeks to determine if the same activation patterns occur post-
treatment with MAAT vs. an attention control condition (supportive therapy; ST) in breast cancer survivors. If
successful, the results of this work will: (1) produce an evidence-based treatment that can be immediately
disseminated to cancer centers and other healthcare settings to treat CRCD and (2) help inform further
treatment development through improved understanding of mechanisms that promote CRCD recovery. MAAT
utilizes a non-drug, CBT approach to enhance self-management, behavioral adaptation, and coping with late
cognitive effects of chemotherapy. MAAT has been evaluated in four previous small trials: 1) a single-group
pilot study (NCI R03); 2) a randomized waitlist control trial (Lance Armstrong Foundation); 3) and a randomized
trial with an active control group condition (supportive therapy; ST) in which both MAAT and ST interventions
were delivered via videoconference (NCI R21). Research with breast cancer survivors shows promising results
with improved subjective and objective cognitive function. In a fourth trial, individuals with cognitive symptoms
after traumatic brain injury (TBI) showed improved cognitive function when treated with MAAT alone or in
combination with methylphenidate relative to those receiving behavioral or pill placebo. While research to date
is favorable, MAAT has not been evaluated in a large RCT with independent, multiple clinicians or at multiple
sites to establish efficacy and generalizability in the breast cancer population. Only one clinician has delivered
MAAT in previous breast cancer survivorship studies and the sample sizes were small. Therefore, the
proposed study makes important methodological improvements using a larger sample size in a multi-site,
multi-clinician RCT with an ST control condition, and reduces survivorship travel burden by delivering both
MAAT and ST over secured videoconference link. The proposed study therefore has the potential for great
clinical and scientific impact, and will help offer effective non-pharmacologic treatment that can be widely
disseminated using mobile technology, especially to rural survivors, to reduce travel and time burden and
improve survivorship care.
Publications
Depressive symptom trajectories in older breast cancer survivors: the Thinking and Living with Cancer Study.
Authors: Nakamura Z.M.
, Small B.J.
, Zhai W.
, Ahles T.A.
, Ahn J.
, Artese A.L.
, Bethea T.N.
, Breen E.C.
, Cohen H.J.
, Extermann M.
, et al.
.
Source: Journal Of Cancer Survivorship : Research And Practice, 2023-11-04 00:00:00.0; , .
EPub date: 2023-11-04 00:00:00.0.
PMID: 37924476
Related Citations
Using Single-Case Experimental Design and Patient-Reported Outcome Measures to Evaluate the Treatment of Cancer-Related Cognitive Impairment in Clinical Practice.
Authors: Ferguson R.J.
, Terhorst L.
, Gibbons B.
, Posluszny D.M.
, Chang H.
, Bovbjerg D.H.
, McDonald B.C.
.
Source: Cancers, 2023-09-20 00:00:00.0; 15(18), .
EPub date: 2023-09-20 00:00:00.0.
PMID: 37760621
Related Citations
Epigenetic aging in older breast cancer survivors and non-cancer controls: preliminary findings from the Thinking and Living with Cancer (TLC) Study.
Authors: Rentscher K.E.
, Bethea T.N.
, Zhai W.
, Small B.J.
, Zhou X.
, Ahles T.A.
, Ahn J.
, Breen E.C.
, Cohen H.J.
, Extermann M.
, et al.
.
Source: Cancer, 2023-06-01 00:00:00.0; , .
EPub date: 2023-06-01 00:00:00.0.
PMID: 37259669
Related Citations
Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls.
Authors: Nudelman K.
, Nho K.
, Zhang M.
, McDonald B.C.
, Zhai W.
, Small B.J.
, Wegel C.E.
, Jacobsen P.B.
, Jim H.S.L.
, Patel S.K.
, et al.
.
Source: Cancers, 2023-05-23 00:00:00.0; 15(11), .
EPub date: 2023-05-23 00:00:00.0.
PMID: 37296840
Related Citations
Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study.
Authors: Mandelblatt J.S.
, Small B.J.
, Zhou X.
, Nakamura Z.M.
, Cohen H.J.
, Ahles T.A.
, Ahn J.
, Bethea T.N.
, Extermann M.
, Graham D.
, et al.
.
Source: Cancer, 2023-04-25 00:00:00.0; , .
EPub date: 2023-04-25 00:00:00.0.
PMID: 37096888
Related Citations
An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
Authors: Tometich D.B.
, Mosher C.E.
, Cyders M.
, McDonald B.C.
, Saykin A.J.
, Small B.J.
, Zhai W.
, Zhou X.
, Jim H.S.L.
, Jacobsen P.
, et al.
.
Source: Annals Of Behavioral Medicine : A Publication Of The Society Of Behavioral Medicine, 2023-04-05 00:00:00.0; 57(3), p. 237-248.
PMID: 36356044
Related Citations
Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study.
Authors: Carroll J.E.
, Nakamura Z.M.
, Small B.J.
, Zhou X.
, Cohen H.J.
, Ahles T.A.
, Ahn J.
, Bethea T.N.
, Extermann M.
, Graham D.
, et al.
.
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2023-01-10 00:00:00.0; 41(2), p. 295-306.
EPub date: 2022-09-30 00:00:00.0.
PMID: 36179271
Related Citations
Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study.
Authors: Van Dyk K.
, Ahn J.
, Zhou X.
, Zhai W.
, Ahles T.A.
, Bethea T.N.
, Carroll J.E.
, Cohen H.J.
, Dilawari A.A.
, Graham D.
, et al.
.
Source: Journal Of Geriatric Oncology, 2022-08-24 00:00:00.0; , .
EPub date: 2022-08-24 00:00:00.0.
PMID: 36030173
Related Citations
Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy.
Authors: McDonald B.C.
, Van Dyk K.
, Deardorff R.L.
, Bailey J.N.
, Zhai W.
, Carroll J.E.
, Root J.C.
, Ahles T.A.
, Mandelblatt J.S.
, Saykin A.J.
.
Source: Breast Cancer Research And Treatment, 2022 Jul; 194(1), p. 113-126.
EPub date: 2022-04-27 00:00:00.0.
PMID: 35476252
Related Citations
Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.
Authors: Root J.C.
, Zhou X.
, Ahn J.
, Small B.J.
, Zhai W.
, Bethea T.
, Carroll J.E.
, Cohen H.J.
, Dilawari A.
, Extermann M.
, et al.
.
Source: Breast Cancer Research And Treatment, 2022-05-19 00:00:00.0; , .
EPub date: 2022-05-19 00:00:00.0.
PMID: 35587324
Related Citations
Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study.
Authors: Bethea T.N.
, Zhai W.
, Zhou X.
, Ahles T.A.
, Ahn J.
, Cohen H.J.
, Dilawari A.A.
, Graham D.M.A.
, Jim H.S.L.
, McDonald B.C.
, et al.
.
Source: Cancer Medicine, 2022-03-22 00:00:00.0; , .
EPub date: 2022-03-22 00:00:00.0.
PMID: 35315588
Related Citations
Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis.
Authors: Small B.J.
, Lange M.
, Zhai W.
, Ahn J.
, Ahles T.A.
, Carroll J.E.
, Cohen H.J.
, Graham D.
, Extermann M.
, Heutte N.
, et al.
.
Source: Breast Cancer Research And Treatment, 2021-11-24 00:00:00.0; , .
EPub date: 2021-11-24 00:00:00.0.
PMID: 34817750
Related Citations
Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction.
Authors: McDonald B.C.
.
Source: Neurotherapeutics : The Journal Of The American Society For Experimental Neurotherapeutics, 2021-08-16 00:00:00.0; , .
EPub date: 2021-08-16 00:00:00.0.
PMID: 34402034
Related Citations
Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.
Authors: Rentscher K.E.
, Zhao X.
, Small B.J.
, Cohen H.J.
, Dilawari A.A.
, Patel S.K.
, Bethea T.N.
, Van Dyk K.M.
, Nakamura Z.M.
, Ahn J.
, et al.
.
Source: Cancer, 2021-06-23 00:00:00.0; , .
EPub date: 2021-06-23 00:00:00.0.
PMID: 34161601
Related Citations
Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment.
Authors: Kesler S.R.
, Sleurs C.
, McDonald B.C.
, Deprez S.
, van der Plas E.
, Nieman B.J.
.
Source: Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, 2021-06-01 00:00:00.0; 39(16), p. 1775-1785.
EPub date: 2021-04-22 00:00:00.0.
PMID: 33886371
Related Citations
Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study.
Authors: Van Dyk K.
, Zhou X.
, Small B.J.
, Ahn J.
, Zhai W.
, Ahles T.
, Graham D.
, Jacobsen P.B.
, Jim H.
, McDonald B.C.
, et al.
.
Source: Jnci Cancer Spectrum, 2021 Apr; 5(2), p. pkab013.
EPub date: 2021-01-27 00:00:00.0.
PMID: 33748669
Related Citations